Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108


CDB-a database for protein heterodimeric complexes.

Aker M, Ohanona S, Fisher S, Katsman E, Dvorkin S, Kopelowitz E, Goldstein M, Barnett-Itzhaki Z, Amitay M.

Protein Eng Des Sel. 2018 Oct 1;31(10):361-365. doi: 10.1093/protein/gzy030.


Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

Aker M, Ganeshan B, Afaq A, Wan S, Groves AM, Arulampalam T.

Dis Colon Rectum. 2019 Feb;62(2):163-170. doi: 10.1097/DCR.0000000000001224.


Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.

Aker M, Boone D, Chandramohan A, Sizer B, Motson R, Arulampalam T.

Abdom Radiol (NY). 2018 Dec;43(12):3213-3219. doi: 10.1007/s00261-018-1627-8.


Expanding the global prevalence of spinocerebellar ataxia type 42.

Ngo K, Aker M, Petty LE, Chen J, Cavalcanti F, Nelson AB, Hassin-Baer S, Geschwind MD, Perlman S, Italiano D, Laganà A, Cavallaro S, Coppola G, Below JE, Fogel BL.

Neurol Genet. 2018 Apr 5;4(3):e232. doi: 10.1212/NXG.0000000000000232. eCollection 2018 Jun. No abstract available. Erratum in: Neurol Genet. 2018 May 18;4(3):e238.


Preventing gatekeeping delays in the diagnosis of rare diseases.

de Vries E, Fransen L, van den Aker M, Meijboom BR.

Br J Gen Pract. 2018 Mar;68(668):145-146. doi: 10.3399/bjgp18X695225. No abstract available.


Inhibition and response to error in remitted major depression.

Aker M, Bø R, Harmer C, Stiles TC, Landrø NI.

Psychiatry Res. 2016 Jan 30;235:116-22. doi: 10.1016/j.psychres.2015.11.038. Epub 2015 Nov 27.


Binge Drinkers Are Fast, Able to Stop - but They Fail to Adjust.

Bø R, Aker M, Billieux J, Landrø NI.

J Int Neuropsychol Soc. 2016 Jan;22(1):38-46. doi: 10.1017/S1355617715001204. Epub 2015 Dec 7.


Serotonin transporter polymorphisms predict response inhibition in healthy volunteers.

Landrø NI, Jonassen R, Clark L, Haug KB, Aker M, Bø R, Berg JP, Neumeister A, Stiles TC.

Neurosci Lett. 2015 Jan 1;584:109-12. doi: 10.1016/j.neulet.2014.10.006. Epub 2014 Oct 17.


More rumination and less effective emotion regulation in previously depressed women with preserved executive functions.

Aker M, Harmer C, Landrø NI.

BMC Psychiatry. 2014 Nov 27;14:334. doi: 10.1186/s12888-014-0334-4.


Executive control of emotional processing: a set-shifting task.

Aker M, Landrø NI.

Clin Neuropsychol. 2014;28(8):1311-20. doi: 10.1080/13854046.2014.984762. Epub 2014 Nov 24.


Estimation of 10-year probability bone fracture in a selected sample of Palestinian people using fracture risk assessment tool.

Aker MB, Taha AS, Zyoud SH, Sawalha AF, Al-Jabi SW, Sweileh WM.

BMC Musculoskelet Disord. 2013 Oct 5;14:284. doi: 10.1186/1471-2474-14-284.


Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.

Deng Z, Glousker G, Molczan A, Fox AJ, Lamm N, Dheekollu J, Weizman OE, Schertzer M, Wang Z, Vladimirova O, Schug J, Aker M, Londoño-Vallejo A, Kaestner KH, Lieberman PM, Tzfati Y.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3408-16. doi: 10.1073/pnas.1300600110. Epub 2013 Aug 19.


Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III.

Gruda R, Brown AC, Grabovsky V, Mizrahi S, Gur C, Feigelson SW, Achdout H, Bar-On Y, Alon R, Aker M, Davis DM, Mandelboim O.

Blood. 2012 Nov 8;120(19):3915-24. doi: 10.1182/blood-2012-02-410795. Epub 2012 Sep 14.


The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioning.

Kedmi M, Dray L, Grisariu S, Resnick IB, Stepensky P, Aker M, Or R, Shapira MY.

Transpl Int. 2012 Dec;25(12):1241-7. doi: 10.1111/j.1432-2277.2012.01559.x. Epub 2012 Sep 13.


Hemin augments growth and hemoglobinization of erythroid precursors from patients with diamond-blackfan anemia.

Fibach E, Aker M.

Anemia. 2012;2012:940260. doi: 10.1155/2012/940260. Epub 2012 May 13.


An SNX10 mutation causes malignant osteopetrosis of infancy.

Aker M, Rouvinski A, Hashavia S, Ta-Shma A, Shaag A, Zenvirt S, Israel S, Weintraub M, Taraboulos A, Bar-Shavit Z, Elpeleg O.

J Med Genet. 2012 Apr;49(4):221-6. doi: 10.1136/jmedgenet-2011-100520.


Kindlin-3 is required for the stabilization of TCR-stimulated LFA-1:ICAM-1 bonds critical for lymphocyte arrest and spreading on dendritic cells.

Feigelson SW, Grabovsky V, Manevich-Mendelson E, Pasvolsky R, Shulman Z, Shinder V, Klein E, Etzioni A, Aker M, Alon R.

Blood. 2011 Jun 30;117(26):7042-52. doi: 10.1182/blood-2010-12-322859. Epub 2011 May 2.


In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency.

Selleri S, Brigida I, Casiraghi M, Scaramuzza S, Cappelli B, Cassani B, Ferrua F, Aker M, Slavin S, Scarselli A, Cancrini C, Marktel S, Grazia Roncarolo M, Aiuti A.

J Allergy Clin Immunol. 2011 Jun;127(6):1368-75.e8. doi: 10.1016/j.jaci.2011.03.004. Epub 2011 Apr 7.


A diagnostic challenge: PCP in a non-HIV patient.

Elias S, Almogi-Hazan O, Aker M, Ben-Yehuda A, Bayya A, Tal Y.

QJM. 2011 Oct;104(10):889-91. doi: 10.1093/qjmed/hcq208. Epub 2010 Nov 3. No abstract available.


Poly(ADP-ribose) polymerase-1 (PARP-1) contributes to the barrier function of a vertebrate chromatin insulator.

Aker M, Bomsztyk K, Emery DW.

J Biol Chem. 2010 Nov 26;285(48):37589-97. doi: 10.1074/jbc.M110.174532. Epub 2010 Sep 27.


Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions.

Manevich-Mendelson E, Feigelson SW, Pasvolsky R, Aker M, Grabovsky V, Shulman Z, Kilic SS, Rosenthal-Allieri MA, Ben-Dor S, Mory A, Bernard A, Moser M, Etzioni A, Alon R.

Blood. 2009 Sep 10;114(11):2344-53. doi: 10.1182/blood-2009-04-218636. Epub 2009 Jul 17.


Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.

Lamm N, Ordan E, Shponkin R, Richler C, Aker M, Tzfati Y.

PLoS One. 2009 May 22;4(5):e5666. doi: 10.1371/journal.pone.0005666.


A retrospective review of the outcome after second or subsequent allogeneic transplantation.

Kedmi M, Resnick IB, Dray L, Aker M, Samuel S, Gesundheit B, Slavin S, Or R, Shapira MY.

Biol Blood Marrow Transplant. 2009 Apr;15(4):483-9. doi: 10.1016/j.bbmt.2009.01.009.


A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus.

Shapira MY, Resnick IB, Dray L, Aker M, Stepensky P, Elad S, Gesundeheidt B, Samuel S, Or R.

Cytotherapy. 2009;11(1):61-7. doi: 10.1080/14653240802644669.


Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG.

N Engl J Med. 2009 Jan 29;360(5):447-58. doi: 10.1056/NEJMoa0805817.


Alefacept treatment for refractory chronic extensive GVHD.

Shapira MY, Abdul-Hai A, Resnick IB, Bitan M, Tsirigotis P, Aker M, Gesundheit B, Slavin S, Or R.

Bone Marrow Transplant. 2009 Feb;43(4):339-43. doi: 10.1038/bmt.2008.324. Epub 2008 Oct 13.


ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients.

Resnick IB, Tsirigotis PD, Shapira MY, Aker M, Bitan M, Samuel S, Abdul-Hai A, Ackerstein A, Or R, Slavin S.

Biol Blood Marrow Transplant. 2008 Apr;14(4):409-17. doi: 10.1016/j.bbmt.2008.01.003.


Intercellular transfer of carcinoembryonic antigen from tumor cells to NK cells.

Stern-Ginossar N, Nedvetzki S, Markel G, Gazit R, Betser-Cohen G, Achdout H, Aker M, Blumberg RS, Davis DM, Appelmelk B, Mandelboim O.

J Immunol. 2007 Oct 1;179(7):4424-34.


Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.

Resnick IB, Aker M, Tsirigotis P, Shapira MY, Abdul-Hai A, Bitan M, Gesundheit B, Amar A, Ackerstein A, Samuel S, Slavin S, Or R.

Bone Marrow Transplant. 2007 Nov;40(10):957-64. Epub 2007 Sep 10.


Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.

Weintraub M, Revel-Vilk S, Charit M, Aker M, Pe'er J.

J Pediatr Hematol Oncol. 2007 Sep;29(9):646-8. Erratum in: J Pediatr Hematol Oncol. 2007 Oct;29(10):728. Pèer, Jacob [corrected to Pe'er, Jacob].


Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.

Aiuti A, Cassani B, Andolfi G, Mirolo M, Biasco L, Recchia A, Urbinati F, Valacca C, Scaramuzza S, Aker M, Slavin S, Cazzola M, Sartori D, Ambrosi A, Di Serio C, Roncarolo MG, Mavilio F, Bordignon C.

J Clin Invest. 2007 Aug;117(8):2233-40.


Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects.

Aker M, Tubb J, Groth AC, Bukovsky AA, Bell AC, Felsenfeld G, Kiem HP, Stamatoyannopoulos G, Emery DW.

Hum Gene Ther. 2007 Apr;18(4):333-43.


NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome.

Gazit R, Aker M, Elboim M, Achdout H, Katz G, Wolf DG, Katzav S, Mandelboim O.

Blood. 2007 May 15;109(10):4306-12. Epub 2007 Jan 25.


Habituation of P3a and P3b brain potentials in men engaged in extreme sports.

Fjell AM, Aker M, Bang KH, Bardal J, Frogner H, Gangås OS, Otnes A, Sønderland NM, Wisløff AK, Walhovd KB.

Biol Psychol. 2007 Apr;75(1):87-94. Epub 2006 Dec 20.


Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.

Or R, Hadar E, Bitan M, Resnick IB, Aker M, Ackerstein A, Samuel S, Tsirigotis P, Gesundheit B, Slavin S, Shapira MY.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1295-301.


Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.

Bitan M, Or R, Shapira MY, Aker M, Resnick IB, Ackerstein A, Samuel S, Elad S, Slavin S.

Biol Blood Marrow Transplant. 2006 Jul;12(7):712-8.


Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.

Resnick IB, Aker M, Shapira MY, Tsirigotis PD, Bitan M, Abdul-Hai A, Samuel S, Ackerstein A, Gesundheit B, Zilberman I, Miron S, Yoffe L, Lvovich A, Slavin S, Or R.

Br J Haematol. 2006 Jun;133(6):649-54.


Integration bias of gammaretrovirus vectors following transduction and growth of primary mouse hematopoietic progenitor cells with and without selection.

Aker M, Tubb J, Miller DG, Stamatoyannopoulos G, Emery DW.

Mol Ther. 2006 Aug;14(2):226-35. Epub 2006 May 2.


Dyskeratosis congenita: dental management of a medically complex child.

Davidovich E, Eimerl D, Aker M, Shapira J, Peretz B.

Pediatr Dent. 2005 May-Jun;27(3):244-8.


Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?

Resnick IB, Averbuch D, Aker M, Engelhard D.

Clin Transplant. 2005 Jun;19(3):427-31.


Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.

Or R, Aker M, Shapira MY, Resnick I, Bitan M, Samuel S, Slavin S.

Springer Semin Immunopathol. 2004 Nov;26(1-2):133-42. Epub 2004 Sep 30. Review.


Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.

Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R.

Clin Transpl. 2003:275-82. Review.


Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial.

Bloom AI, Shapira MY, Or R, Sasson T, Resnick IB, Zilberman I, Verstandig A, Aker M, Slavin S, Muszkat M.

Clin Ther. 2004 Mar;26(3):407-14.


LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds.

Kinashi T, Aker M, Sokolovsky-Eisenberg M, Grabovsky V, Tanaka C, Shamri R, Feigelson S, Etzioni A, Alon R.

Blood. 2004 Feb 1;103(3):1033-6. Epub 2003 Oct 9.


A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow.

Alon R, Aker M, Feigelson S, Sokolovsky-Eisenberg M, Staunton DE, Cinamon G, Grabovsky V, Shamri R, Etzioni A.

Blood. 2003 Jun 1;101(11):4437-45. Epub 2003 Feb 20.


Intra-arterial catheter directed therapy for severe graft-versus-host disease.

Shapira MY, Bloom AI, Or R, Sasson T, Nagler A, Resnick IB, Aker M, Zilberman I, Slavin S, Verstanding A.

Br J Haematol. 2002 Dec;119(3):760-4.


A primary immunodeficiency disorder associated with absence of lymphoid germinal centers.

Eisenstein EM, Aker M, Savoldi G, Jaffe R, Prus D.

J Clin Immunol. 2002 Sep;22(5):297-305.


Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.

Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, Aker M, Naparstek E, Nagler A, Slavin S.

Blood. 2003 Jan 15;101(2):441-5. Epub 2002 Sep 19.


Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.

Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.

Transfus Apher Sci. 2002 Oct;27(2):159-66. Review.


Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C.

Science. 2002 Jun 28;296(5577):2410-3.

Supplemental Content

Support Center